Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses combinations with immunotherapy for patients with head and neck cancer.
- Dr. Bauml on Immunotherapy Combinations in Head and Neck Cancer ( Download)
- Dr. Bauml Discusses Biomarkers in Head and Neck Cancer ( Download)
- Dr. Bauml on CAR T-Cell Therapy in Head and Neck Cancer ( Download)
- Dr. Joshua M. Bauml on Pembrolizumab Versus Chemo in Head and Neck Cancers ( Download)
- Dr. Bauml on the Unmet Need in Head and Neck Cancer ( Download)
- Dr. Cohen on Immunotherapy Combinations in Head and Neck Cancer ( Download)
- Dr. Joshua M. Bauml on the Impact of Pembrolizumab in Head and Neck Cancer ( Download)
- Dr. Cohen Discusses Immunotherapy Combinations in Head and Neck Cancer ( Download)
- Immunotherapy Combinations for HNSCC ( Download)
- Dr. Bauml on KEYNOTE-055 Study for Patients With HNSCC ( Download)
- Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC ( Download)
- Dr. Bauml on Locally Ablative Therapy in Oligometastatic NSCLC ( Download)
- ASCO/ESMO 2020 - Head and Neck Cancer Updates - JAVELIN100 Trial Update ( Download)
- ASCO 2016 – Treating Head and Neck Cancer – Immunotherapy as First-Line Treatment, Combinations ( Download)
- Dr. Burtness on the Future of Immunotherapy in Head and Neck Cancer ( Download)